INSERM UMR-1100, CEPR "Centre d'Etude des Pathologies Respiratoires", Tours, France.
Université de Tours, France.
FEBS J. 2020 Sep;287(18):4068-4081. doi: 10.1111/febs.15229. Epub 2020 Feb 24.
Polymorphonuclear neutrophils contain at least four serine endopeptidases, namely neutrophil elastase (NE), proteinase 3 (PR3), cathepsin G (CatG), and NSP4, which contribute to the regulation of infection and of inflammatory processes. In physiological conditions, endogenous inhibitors including α2-macroglobulin (α2-M), serpins [α1-proteinase inhibitor (α1-PI)], monocyte neutrophil elastase inhibitor (MNEI), α1-antichymotrypsin, and locally produced chelonianins (elafin, SLPI) control excessive proteolytic activity of neutrophilic serine proteinases. In contrast to human NE (hNE), hPR3 is weakly inhibited by α1-PI and MNEI but not by SLPI. α2-M is a large spectrum inhibitor that traps a variety of proteinases in response to cleavage(s) in its bait region. We report here that α2-M was more rapidly processed by hNE than hPR3 or hCatG. This was confirmed by the observation that the association between α2-M and hPR3 is governed by a k in the ≤ 10 m ·s range. Since α2-M-trapped proteinases retain peptidase activity, we first predicted the putative cleavage sites within the α2-M bait region (residues 690-728) using kinetic and molecular modeling approaches. We then identified by mass spectrum analysis the cleavage sites of hPR3 in a synthetic peptide spanning the 39-residue bait region of α2-M (39pep-α2-M). Since the 39pep-α2-M peptide and the corresponding bait area in the whole protein do not contain sequences with a high probability of specific cleavage by hPR3 and were indeed only slowly cleaved by hPR3, it can be concluded that α2-M is a poor inhibitor of hPR3. The resistance of hPR3 to inhibition by endogenous inhibitors explains at least in part its role in tissue injury during chronic inflammatory diseases and its well-recognized function of major target autoantigen in granulomatosis with polyangiitis.
多形核中性粒细胞至少含有四种丝氨酸内肽酶,即中性粒细胞弹性蛋白酶(NE)、蛋白酶 3(PR3)、组织蛋白酶 G(CatG)和 NSP4,它们有助于调节感染和炎症过程。在生理条件下,包括α2-巨球蛋白(α2-M)、丝氨酸蛋白酶抑制剂[α1-蛋白酶抑制剂(α1-PI)]、单核细胞中性粒细胞弹性蛋白酶抑制剂(MNEI)、α1-抗胰蛋白酶和局部产生的 Chelonainins(elafin、SLPI)在内的内源性抑制剂控制中性粒细胞丝氨酸蛋白酶的过度蛋白水解活性。与人类 NE(hNE)相比,hPR3 被 α1-PI 和 MNEI 弱抑制,但不受 SLPI 抑制。α2-M 是一种广谱抑制剂,它在诱饵区域的切割反应中捕获多种蛋白酶。我们在这里报告,α2-M 比 hPR3 或 hCatG 更快地被 hNE 处理。这通过观察到α2-M 与 hPR3 的结合受 k 值在 ≤10 m·s 范围内控制得到证实。由于被 α2-M 捕获的蛋白酶保留肽酶活性,我们首先使用动力学和分子建模方法预测α2-M 诱饵区域(残基 690-728)内的假定切割位点。然后,通过质谱分析鉴定出跨越α2-M 的 39 个残基诱饵区域(39pep-α2-M)的合成肽中的 hPR3 切割位点。由于 39pep-α2-M 肽和整个蛋白质中的相应诱饵区域不包含高概率被 hPR3 特异性切割的序列,并且实际上仅被 hPR3 缓慢切割,因此可以得出结论,α2-M 是 hPR3 的不良抑制剂。hPR3 对内源性抑制剂的抑制作用的抵抗力至少部分解释了其在慢性炎症性疾病期间组织损伤中的作用及其在肉芽肿性多血管炎中的公认的主要靶自身抗原功能。